Biohit Oyj Management

Management criteria checks 2/4

Biohit Oyj's CEO is Jussi Hahtela, appointed in Sep 2022, has a tenure of 2.33 years. directly owns 0.26% of the company’s shares, worth €97.60K. The average tenure of the management team and the board of directors is 2.3 years and 5.8 years respectively.

Key information

Jussi Hahtela

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownership0.3%
Management average tenure2.3yrs
Board average tenure5.8yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Jussi Hahtela (51 yo)

2.3yrs

Tenure

Mr. Jussi Hahtela serves as Chief Executive Officer of Biohit Oyj from September 02, 2022 and serves as its President. He served as Chief Financial Officer at Biohit Oyj since June 4, 2021. He is responsib...


Leadership Team

NamePositionTenureCompensationOwnership
Osmo Suovaniemi
Founder37yrs€14.00k14.15%
€ 5.2m
Jussi Hahtela
President & CEO2.3yrsno data0.26%
€ 97.6k
Jussi Sorvo
Chief Financial Officer2.3yrsno data0.11%
€ 39.0k
Graham Johnson
Head of Global Sales & Marketing1.2yrsno datano data
Yulia Kubacheva
Head of Diagnostics Department - Biohit Russia18.6yrsno datano data
Ilari Patrakka
Chief Commercial Officer1.2yrsno data0.13%
€ 49.1k
Panu Hendolin
R&D Directorno datano data0.087%
€ 32.2k

2.3yrs

Average Tenure

51yo

Average Age

Experienced Management: 0DRP's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Osmo Suovaniemi
Founder37yrs€14.00k14.15%
€ 5.2m
Vesa-Pekka Silaskivi
Independent Chairman of the Board1.6yrs€8.00kno data
Mårten Wikström
Member of Scientific Advisory Boardno datano datano data
Pentti Sipponen
Scientific Advisorno datano datano data
Seppo Sarna
Scientific Advisorno datano datano data
Kalle Härkönen
Independent Director2.6yrs€14.00k0.029%
€ 10.6k
Matti Harkonen
Scientific Advisorno data€3.00k2.14%
€ 793.4k
Lea Paloheimo
Independent Director5.8yrs€14.00k0.046%
€ 17.1k
Martti Marvola
Member of Scientific Advisory Boardno datano datano data
Feng Liu
Director6.4yrs€12.00kno data

5.8yrs

Average Tenure

73yo

Average Age

Experienced Board: 0DRP's board of directors are considered experienced (5.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 04:17
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biohit Oyj is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Antti SiltanenInderes Oy